Evidence map›Paper›PMID 40080204›Full record

ArticleClinical and experimental medicine2025

Predicting sentinel lymph node metastasis in breast cancer: a study based on the SEER database.

Qingyang Li, Hu Xu, Baoshi Bao, Yujiao Xie, Shiqi Guo, Zhaofeng Gao, Siyi Chen, Jiahong Sun, Li Zhu, Jiandong Wang

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qingyang LiMedical School of Chinese PLA, Beijing, 100853, China.
Hu XuDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Baoshi BaoDepartment of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Yujiao XieSchool of Medicine, Nankai University, Tianjin, 300110, China.
Shiqi GuoMedical School of Chinese PLA, Beijing, 100853, China.
Zhaofeng GaoSchool of Medicine, Nankai University, Tianjin, 300110, China.
Siyi ChenMedical School of Chinese PLA, Beijing, 100853, China.
Jiahong SunMedical School of Chinese PLA, Beijing, 100853, China.
Li ZhuMedical School of Chinese PLA, Beijing, 100853, China. zhuxiaoli0430@163.com.
Jiandong WangMedical School of Chinese PLA, Beijing, 100853, China. Vicky1968@163.com.

Funding

National Natural Science Foundation of China 62476285
6 · The paper itself

Abstract

backgroundSentinel lymph node biopsy (SLNB), a standard surgical procedure for clinically axillary-negative breast cancer patients, significantly reduces complications compared with axillary lymph node dissection, but it is still a relatively invasive procedure with some complications, affecting patient's quality of life. To identify patients who might benefit from avoiding SLNB, this study aimed to develop a nomogram for predicting sentinel lymph node metastasis (SLNM) in breast cancer patients using the SEER database.

methodsWe identified breast cancer patients whose 1-5 lymph nodes were examined in the SEER database as those who underwent SLNB. Patients were randomly assigned to the training and validation cohorts at a 3:1 ratio. Univariate and multivariate logistic regression were used to evaluate the relationships between SLNM and patients' clinicopathological characteristics. A nomogram was constructed, and its performance was validated via ROC curves, calibration curves, and decision curve analysis.

resultsAge, race, primary site, T stage, M stage, histological grade, pathological type, estrogen receptor status, and progesterone receptor status are independent predictive factors for SLNM in patients with breast cancer. We successfully developed a predictive nomogram for sentinel lymph node status, with AUC values of 0.711 and 0.700 for the training and validation cohorts, respectively.

conclusionOur study successfully established an SLNM nomogram that provides richer predictive information. The model exhibits good clinical efficacy and serves as a reference value for populations potentially exempt from SLNB.

Indexed as

Breast NeoplasmsLymphatic MetastasisSentinel Lymph NodeAdultAgedFemaleHumansMiddle AgedNomogramsROC CurveSEER ProgramSentinel Lymph Node BiopsyBreast cancerNomogramPredictive modelRisk factorsSEER databaseSentinel lymph node biopsySentinel lymph node metastasis

Identifiers

PMID40080204
PMCPMC11906503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.